RTW Investments, L.P., 10% Owner at Athira Pharma, Inc. (ATHA), bought 2,285,131 shares at $17.00 ($12.8M) on 2020-09-18, disclosed to the SEC on 2020-09-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,535,131 | $0 | 0.0% |
| 2 | $17.00 | 750,000 | $12.8M | 100.0% |
| Total | $5.58 avg | 2,285,131 | $12.8M | 100% |
| Filing → |
| OBIO | BUY | 2025-04-29 | $253K | — | Filing → |
| DMTK | SELL | 2022-11-08 | $177K | — | Filing → |
| RCKT | BUY | 2022-10-11 | $20.0M | — | Filing → |